Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
The purpose of this study is to provide theoretical and real world evidence for the optimization of antiviral treatment by IFN combined with Nucleosides analog in HBeAg positive chronic hepatitis B patients aged 1-16 years,so that the functional cure could be achieved in the greatest extent in pediatric patients
Epistemonikos ID: b71f4911d735c52d5f97b74d658426ca2eff9882
First added on: Nov 24, 2021